NCT00004216View on ClinicalTrials.gov

VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 1999

Study Completion Date

January 31, 2008

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

salmonella VNP20009

DRUG

cefixime

DRUG

ceftriaxone sodium

DRUG

ciprofloxacin

DRUG

trimethoprim-sulfamethoxazole

Trial Locations (3)

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

75246

Mary Crowley Medical Research Center, Dallas

02215

Beth Israel Deaconess Medical Center, Boston

Sponsors
All Listed Sponsors
lead

Vion Pharmaceuticals

INDUSTRY

NCT00004216 - VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy | Biotech Hunter | Biotech Hunter